Chroma ATE Inc (2360)
Taiwan Stock Exchange · Taiwan · prices in TWD · close of 19 Oct 2026
Key indicators
| Last close | TWD 2,005.00 |
|---|---|
| 52-week range | 593.98 – 2,771.56 |
| Return, 1 month / 3 months | −3.6% / +8.4% |
| Return, 1 year / 3 years | +218.9% / +669.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 41 |
| Volatility (1 year) | 68.4% |
| Worst drawdown (1 year) | -30.1% |
| Average daily value traded | 5,415.93M TWD |
| Dividend yield | 1.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Chroma ATE Inc is a Taiwanese maker of precision test and measurement instruments and automated test equipment. Its products include programmable power supplies, electronic loads, power meters and test systems used to check power electronics, displays, batteries and related components. Customers are mainly manufacturers and engineering teams in electronics, automotive and energy-related industries who need reliable testing and measurement in their production and development work. The company is based in Taoyuan, Taiwan.
The shares are listed on the Taiwan Stock Exchange in Taiwan under the code 2360, and the price on this page is in New Taiwan dollars (TWD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Chroma ATE Inc (2360) trades on the Taiwan Stock Exchange in Taiwan. It last closed at TWD 2,005.00 on 19 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 338 of 1,101 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 218.9% and over the last three months it rose 8.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Taiwan Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 10.2% | ||
| From 52-week high | -23.0% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 8.4% | ||
| 6-month return | -10.3% | ||
| 12-month return, skipping the last month | 230.9% | ||
| Stability (higher is calmer) | 31 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 68.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.1% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 5,415.93M TWD | ||
| Zero-volume days | 0.0% | ||
| Income | 39 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.0% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −15.2% |
|---|---|
| 1 month | −3.6% |
| 3 months | +8.4% |
| 6 months | −10.3% |
| 1 year | +218.9% |
| 3 years | +669.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 2,161.80 / 1,819.84 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 141.03 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Jun 2026 | TWD 19.5000 |
| 20 Jun 2025 | TWD 9.0000 |
| 12 Jun 2024 | TWD 6.6001 |
| 7 Jul 2023 | TWD 8.0006 |
| 25 Jul 2022 | TWD 6.9809 |
| 23 Jun 2021 | TWD 4.4996 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Taiwan Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.